| pubmed-article:15300189 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15300189 | lifeskim:mentions | umls-concept:C0346647 | lld:lifeskim |
| pubmed-article:15300189 | lifeskim:mentions | umls-concept:C0035547 | lld:lifeskim |
| pubmed-article:15300189 | lifeskim:mentions | umls-concept:C1136031 | lld:lifeskim |
| pubmed-article:15300189 | lifeskim:mentions | umls-concept:C0679199 | lld:lifeskim |
| pubmed-article:15300189 | lifeskim:mentions | umls-concept:C0599894 | lld:lifeskim |
| pubmed-article:15300189 | lifeskim:mentions | umls-concept:C0302350 | lld:lifeskim |
| pubmed-article:15300189 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:15300189 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:15300189 | lifeskim:mentions | umls-concept:C1711351 | lld:lifeskim |
| pubmed-article:15300189 | lifeskim:mentions | umls-concept:C0127400 | lld:lifeskim |
| pubmed-article:15300189 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:15300189 | pubmed:dateCreated | 2004-8-9 | lld:pubmed |
| pubmed-article:15300189 | pubmed:abstractText | Ribonucleotide reductase M2 subunit (RRM2) overexpression enhances tumor chemoresistance and cellular invasiveness. We hypothesized that the RNA interference (RNAi) induced by retrovirally delivered small interfering RNA (siRNA) would sensitize pancreatic adenocarcinoma cells to gemcitabine and attenuate their invasive potential. | lld:pubmed |
| pubmed-article:15300189 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15300189 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15300189 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15300189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15300189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15300189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15300189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15300189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15300189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15300189 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15300189 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:15300189 | pubmed:issn | 0039-6060 | lld:pubmed |
| pubmed-article:15300189 | pubmed:author | pubmed-author:AshleyStanley... | lld:pubmed |
| pubmed-article:15300189 | pubmed:author | pubmed-author:ZinnerMichael... | lld:pubmed |
| pubmed-article:15300189 | pubmed:author | pubmed-author:WhangEdward... | lld:pubmed |
| pubmed-article:15300189 | pubmed:author | pubmed-author:ItoHiromichiH | lld:pubmed |
| pubmed-article:15300189 | pubmed:author | pubmed-author:DuxburyMark... | lld:pubmed |
| pubmed-article:15300189 | pubmed:author | pubmed-author:BenoitEricE | lld:pubmed |
| pubmed-article:15300189 | pubmed:copyrightInfo | Copyright 2004 Elsevier Inc. | lld:pubmed |
| pubmed-article:15300189 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15300189 | pubmed:volume | 136 | lld:pubmed |
| pubmed-article:15300189 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15300189 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15300189 | pubmed:pagination | 261-9 | lld:pubmed |
| pubmed-article:15300189 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15300189 | pubmed:meshHeading | pubmed-meshheading:15300189... | lld:pubmed |
| pubmed-article:15300189 | pubmed:meshHeading | pubmed-meshheading:15300189... | lld:pubmed |
| pubmed-article:15300189 | pubmed:meshHeading | pubmed-meshheading:15300189... | lld:pubmed |
| pubmed-article:15300189 | pubmed:meshHeading | pubmed-meshheading:15300189... | lld:pubmed |
| pubmed-article:15300189 | pubmed:meshHeading | pubmed-meshheading:15300189... | lld:pubmed |
| pubmed-article:15300189 | pubmed:meshHeading | pubmed-meshheading:15300189... | lld:pubmed |
| pubmed-article:15300189 | pubmed:meshHeading | pubmed-meshheading:15300189... | lld:pubmed |
| pubmed-article:15300189 | pubmed:meshHeading | pubmed-meshheading:15300189... | lld:pubmed |
| pubmed-article:15300189 | pubmed:meshHeading | pubmed-meshheading:15300189... | lld:pubmed |
| pubmed-article:15300189 | pubmed:meshHeading | pubmed-meshheading:15300189... | lld:pubmed |
| pubmed-article:15300189 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15300189 | pubmed:articleTitle | Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer. | lld:pubmed |
| pubmed-article:15300189 | pubmed:affiliation | Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. | lld:pubmed |
| pubmed-article:15300189 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15300189 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15300189 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15300189 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15300189 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15300189 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15300189 | lld:pubmed |
